About us
Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Our Strategic Road Map defines strategies, standards, and policy frameworks to support responsible global use of genomic and related health data.
Discover how a meeting of 50 leaders in genomics and medicine led to an alliance uniting more than 5,000 individuals and organisations to benefit human health.
GA4GH Inc. is a not-for-profit organisation that supports the global GA4GH community.
The GA4GH Council, consisting of the Executive Committee, Strategic Leadership Committee, and Product Steering Committee, guides our collaborative, globe-spanning alliance.
The Funders Forum brings together organisations that offer both financial support and strategic guidance.
The EDI Advisory Group responds to issues raised in the GA4GH community, finding equitable, inclusive ways to build products that benefit diverse groups.
Distributed across a number of Host Institutions, our staff team supports the mission and operations of GA4GH.
Curious who we are? Meet the people and organisations across six continents who make up GA4GH.
More than 500 organisations connected to genomics — in healthcare, research, patient advocacy, industry, and beyond — have signed onto the mission and vision of GA4GH as Organisational Members.
These core Organisational Members are genomic data initiatives that have committed resources to guide GA4GH work and pilot our products.
This subset of Organisational Members whose networks or infrastructure align with GA4GH priorities has made a long-term commitment to engaging with our community.
Local and national organisations assign experts to spend at least 30% of their time building GA4GH products.
Anyone working in genomics and related fields is invited to participate in our inclusive community by creating and using new products.
Wondering what GA4GH does? Learn how we find and overcome challenges to expanding responsible genomic data use for the benefit of human health.
Study Groups define needs. Participants survey the landscape of the genomics and health community and determine whether GA4GH can help.
Work Streams create products. Community members join together to develop technical standards, policy frameworks, and policy tools that overcome hurdles to international genomic data use.
GIF solves problems. Organisations in the forum pilot GA4GH products in real-world situations. Along the way, they troubleshoot products, suggest updates, and flag additional needs.
NIF finds challenges and opportunities in genomics at a global scale. National programmes meet to share best practices, avoid incompatabilities, and help translate genomics into benefits for human health.
Communities of Interest find challenges and opportunities in areas such as rare disease, cancer, and infectious disease. Participants pinpoint real-world problems that would benefit from broad data use.
Find out what’s happening with up to the minute meeting schedules for the GA4GH community.
See all our products — always free and open-source. Do you work on cloud genomics, data discovery, user access, data security or regulatory policy and ethics? Need to represent genomic, phenotypic, or clinical data? We’ve got a solution for you.
All GA4GH standards, frameworks, and tools follow the Product Development and Approval Process before being officially adopted.
Learn how other organisations have implemented GA4GH products to solve real-world problems.
Help us transform the future of genomic data use! See how GA4GH can benefit you — whether you’re using our products, writing our standards, subscribing to a newsletter, or more.
Help create new global standards and frameworks for responsible genomic data use.
Align your organisation with the GA4GH mission and vision.
Want to advance both your career and responsible genomic data sharing at the same time? See our open leadership opportunities.
Join our international team and help us advance genomic data use for the benefit of human health.
Share your thoughts on all GA4GH products currently open for public comment.
Solve real problems by aligning your organisation with the world’s genomics standards. We offer software dvelopers both customisable and out-of-the-box solutions to help you get started.
Learn more about upcoming GA4GH events. See reports and recordings from our past events.
Speak directly to the global genomics and health community while supporting GA4GH strategy.
Be the first to hear about the latest GA4GH products, upcoming meetings, new initiatives, and more.
Questions? We would love to hear from you.
Read news, stories, and insights from the forefront of genomic and clinical data use.
Attend an upcoming GA4GH event, or view meeting reports from past events.
See new projects, updates, and calls for support from the Work Streams.
Read academic papers coauthored by GA4GH contributors.
Listen to our podcast OmicsXchange, featuring discussions from leaders in the world of genomics, health, and data sharing.
Check out our videos, then subscribe to our YouTube channel for more content.
View the latest GA4GH updates, Genomics and Health News, Implementation Notes, GDPR Briefs, and more.
Discover all things GA4GH: explore our news, events, videos, podcasts, announcements, publications, and newsletters.
12 Oct 2018
A paper published in the October, 2018 special issue of Human Mutation features the ways in which the Clinical Genome Resource (ClinGen) is contributing to GA4GH standards development.
In a 25-paper special issue of the journal Human Mutation, members of the Clinical Genome Resource (ClinGen) discuss how it is advancing knowledge on the genetic precursors to disease. ClinGen provides a platform for research and clinical experts to review genetic variants that have been associated with disease and determine whether they are actually pathogenic. These expert classifications are submitted to ClinVar, an NIH-hosted database of variant information which clinicians draw from to diagnose and treat patients and which researchers use to guide their studies.
One of the papers in the special issue, “ClinGen Advancing Genomic Data-Sharing Standards as a GA4GH Driver Project,” is co-authored by members of both the ClinGen and GA4GH communities and highlights the ways in which ClinGen, as a GA4GH Driver Project, is contributing to standards development underway in the GA4GH Work Streams.
In particular, ClinGen is deeply involved with the GA4GH Genomic Knowledge Standards (GKS), Clinical and Phenotypic Data Capture (CPDC), and Discovery Work Streams. Through these interactions, the group is helping to develop (i) a standard model for computer readable variant representation, (ii) a data model for linking variant data to annotations, (iii) a network for sharing knowledge about genomic variants and associated clinical interpretations, and (iv) recommended phenotype & disease ontologies and best practices for their use in genomic medicine.
Genomic variants are described with many naming conventions, making it difficult to unambiguously define a variant and ensure the accurate use of associated knowledge. GKS seeks to harmonise this information, and is drawing significantly on prior work from ClinGen’s Data Modeling Work Group, as well as other organizations. The ClinGen Allele Registry plans to define a pilot project to implement the GKS Variant Representation specification, which is currently available in a beta version and proposes a language and nomenclature for describing variation. GKS is also developing a common data model to guide how variant evidence is linked to clinical information with a standard format, based in part on use cases and preliminary work done within ClinGen.
With input from GKS and CPDC, the Discovery Work Stream is developing standards for sharing variant classifications and supporting evidence such as that contained in ClinVar. The standards developed in this effort will be foundational for ClinGen’s knowledge bases. In addition, ClinGen is also implementing the standard phenotype and disease ontologies and best practices, and methods for exchanging such information, being developed within CPDC.
These efforts represent the most recent iteration of a long history of collaboration between ClinGen and GA4GH. Together the two groups developed guidelines for sharing pediatric genomic data and variant-level information in ClinVar, as well as consent resources for clinical genomic data sharing. ClinGen has also been a key contributor to the BRCA Challenge, one of GA4GH’s four early demonstration projects.
“The close partnership between ClinGen and GA4GH illustrates how clinical research consortia can be leveraged to contribute significantly to even larger initiatives,” said Robert Freimuth, an Assistant Professor of Medical Informatics at the Mayo Clinic, co-lead of the GA4GH GKS Work Stream, and a member of the ClinGen Data Exchange and EHR Working Groups. “The success of this collaboration is a model for the development of the shared resources that are imperative for the scalable implementation of clinical genomics.”
Read more about the full issue in the NIH press release.
###
ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research.
The Global Alliance for Genomics and Health (GA4GH) is an international, nonprofit alliance formed in 2013 to accelerate the potential of research and medicine to advance human health. Bringing together 500+ leading organizations working in healthcare, research, patient advocacy, life science, and information technology, the GA4GH community is working together to create frameworks and standards to enable the responsible, voluntary, and secure sharing of genomic and health-related data. All of GA4GH builds upon the Framework for Responsible Sharing of Genomic and Health-Related Data.